Jonathan Hobson, MD
Clinical Cardiac Electrophysiology · Safety Harbor, FLNPI 1932162823
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $9,493 of the $13,875 with a category attached, or 68.4%. 23 manufacturers reported payments, led by Medtronic at 49.6% of the total. Reporting peaked in 2019 at $4,095 and has fallen 80.1% since, to $817 in 2025. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in FL, where the typical reported total is $25,729.
Across 355 payments — averaging $39.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$7K
- Biotronik Inc.$4K
- Boston Scientific$576
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$411
- Biosense Webster, Inc.$361
- Acutus Medical, Inc.$220
- plus $1K from 17 others
Across 495 payments — averaging $506.75 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$198K
- Biotronik Inc.$53K
What the payments were for
- Consulting fees$2,82520%
- Travel & lodging$1,54511%
- Food & beverage$9,49368%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 168 | $6,884 |
| Biotronik Inc. | 65 | $4,030 |
| Boston Scientific | 13 | $576 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 25 | $411 |
| Biosense Webster, Inc. | 13 | $361 |
| Acutus Medical, Inc. | 1 | $220 |
| Amgen | 12 | $186 |
| Novartis | 10 | $148 |
| Johnson & Johnson | 8 | $143 |
| Cvrx, Inc. | 1 | $130 |
| Sanofi-aventis U.S. LLC | 5 | $99 |
| Amarin Pharma, Inc. | 6 | $97 |
| Abbott | 4 | $87 |
| Pfizer | 4 | $77 |
| E.r. Squibb & Sons, L.L.C. | 5 | $70 |
| Alnylam Pharmaceuticals Inc. | 2 | $57 |
| Kestra Medical Technology Services, Inc. | 2 | $55 |
| Portola Pharmaceuticals, LLC | 1 | $53 |
| Esperion Therapeutics, Inc. | 3 | $46 |
| Abiomed | 1 | $46 |
| Elutia, Inc. | 3 | $42 |
| AstraZeneca | 2 | $34 |
| Novo Nordisk | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Micra$674
- Adapta$406
- CapSure Sense$158
- RESONATE EL ICD VR$154
- Barostim Neo System$130
- GENERAL TACHY$127
- LifeVest$126
- EMBLEM$125
- Carto 3 System$123
- COBALT DR MRI SURESCAN$120
- Claria MRI$118
- Azure$116
- MyCareLink$113
- PACEART SYSTEM ECG MODULE$111
- TYRX$102
How this compares
$13,875 in reported general payments places this provider in the 30th percentile of 249 clinical cardiac electrophysiology providers in Florida.
See all clinical cardiac electrophysiology providers in Florida →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 659 | $677,458 |
| XareltoRivaroxaban | 323 | $384,632 |
| EntrestoSacubitril/Valsartan | 99 | $114,802 |
| MultaqDronedarone Hcl | 27 | $31,725 |
| FarxigaDapagliflozin Propanediol | 26 | $22,737 |
| JardianceEmpagliflozin | 27 | $19,816 |
| BrilintaTicagrelor | 12 | $12,237 |
| Dabigatran EtexilateDabigatran Etexilate Mesylate | 37 | $12,021 |
| Metoprolol Succinate | 633 | $8,572 |
| SotalolSotalol Hcl | 253 | $5,551 |
| Propafenone Hcl ErPropafenone Hcl | 33 | $5,411 |
| Ranolazine ErRanolazine | 12 | $4,660 |
| Amiodarone Hcl | 252 | $4,429 |
| Flecainide Acetate | 105 | $3,180 |
| Losartan Potassium | 301 | $2,651 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $77 | $677,458659 claims |
| Johnson & JohnsonXarelto | $143 | $384,632323 claims |
| NovartisEntresto | $148 | $114,80299 claims |
| AstraZenecaFarxiga, Brilinta | $34 | $34,97438 claims |
| Sanofi-aventis U.S. LLCMultaq | $99 | $31,72527 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 30th percentile of 249 clinical cardiac electrophysiology providers in Florida.
Other clinical cardiac electrophysiology in Safety Harbor
- Usman SiddiquiWinter Park$1.2M
- Jose Osorio FilhoMiami$1.2M
- David KenigsbergFort Lauderdale$1M
- Raul WeissMiami Beach$887K
- Naushad ShaikKissimmee$691K
- Parikshit SharmaWeston$462K
- Saumil OzaJacksonville$462K
- Brian BetenskySarasota$412K
- Antonio MorettaSarasota$312K
- Marcelo JimenezAtlantis$295K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.